Augmentation Therapy for AATD
Alpha-1 Antitrypsin Augmentation Therapy is a specialized treatment for individuals with Alpha-1 Antitrypsin Deficiency, a genetic condition that can lead to serious lung and liver disease. This therapy replaces the missing AAT protein to help protect the lungs.
Alpha-1 Antitrypsin Deficiency (AATD) is an inherited condition where the liver produces insufficient alpha-1 antitrypsin, a protein that protects the lungs from damage during inflammation.
Weekly infusions of purified AAT protein travel through the bloodstream to the lungs, where they protect tissue from damage caused by neutrophil elastase, an enzyme that can break down lung tissue.
Many people with AATD are undiagnosed. If you experience these symptoms, talk to your doctor about testing.
Difficulty breathing, especially with physical activity, is often the first symptom noticed by patients.
Persistent respiratory symptoms that may be mistaken for asthma or chronic bronchitis.
Frequent lung infections due to reduced lung function and impaired immune protection.
Development of emphysema before age 45, particularly in non-smokers, is a key indicator of AATD.
Our nurses are experienced with all FDA-approved AAT therapies
Alpha1-proteinase inhibitor
Alpha1-proteinase inhibitor
Alpha1-proteinase inhibitor
Alpha1-proteinase inhibitor
Since augmentation therapy requires weekly lifelong infusions, home treatment helps you maintain your normal life.
Receive treatment in your familiar environment
Infusions scheduled around your life
Dedicated nurse throughout your infusion
Avoid exposure to clinical settings